Exagen (XGN) News Today → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free XGN Stock Alerts $1.87 -0.01 (-0.53%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 8:35 PM | finance.yahoo.comExagen Inc. (XGN)May 17 at 12:43 PM | insidertrades.comInsider Buying: Exagen Inc. (NASDAQ:XGN) CEO Buys 40,401 Shares of StockMay 17 at 4:36 AM | americanbankingnews.comExagen Inc. (NASDAQ:XGN) to Post FY2024 Earnings of ($1.18) Per Share, Cantor Fitzgerald ForecastsMay 16, 2024 | americanbankingnews.comExagen Inc. Expected to Post Q2 2024 Earnings of ($0.36) Per Share (NASDAQ:XGN)May 15, 2024 | finance.yahoo.comExagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ...May 15, 2024 | americanbankingnews.comExagen (NASDAQ:XGN) Price Target Raised to $7.00 at Cantor FitzgeraldMay 15, 2024 | msn.comHealthcare Shares Soar Following Major Price Target IncreaseMay 14, 2024 | markets.businessinsider.comExagen’s Strong Q1 Earnings and Growth Potential Justify Buy RatingMay 14, 2024 | finance.yahoo.comExagen First Quarter 2024 Earnings: Beats ExpectationsMay 13, 2024 | msn.comExagen beats top-line and bottom-line estimates; raises FY24 outlookMay 13, 2024 | markets.businessinsider.comExagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearMay 13, 2024 | investorplace.comXGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024May 13, 2024 | globenewswire.comExagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearMay 11, 2024 | americanbankingnews.comShort Interest in Exagen Inc. (NASDAQ:XGN) Declines By 64.7%May 11, 2024 | americanbankingnews.comExagen (XGN) Scheduled to Post Earnings on MondayApril 30, 2024 | finance.yahoo.comExagen to Announce First Quarter 2024 Results on May 13, 2024April 26, 2024 | globenewswire.comExagen Inc. Announces Changes to the Board of DirectorsApril 16, 2024 | morningstar.comExagen Inc Ordinary SharesMarch 21, 2024 | finance.yahoo.comAnalyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual ReportMarch 20, 2024 | seekingalpha.comExagen Inc. (XGN) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | markets.businessinsider.comBuy Rating Affirmed for Exagen on Strong Financials and Strategic Growth InitiativesMarch 20, 2024 | finance.yahoo.comExagen Full Year 2023 Earnings: Beats ExpectationsMarch 19, 2024 | finance.yahoo.comExagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | markets.businessinsider.comExagen’s Strong Q4 Performance and Positive Outlook Justify Buy RatingMarch 18, 2024 | markets.businessinsider.comHere's what to expect from Exagen's earningsMarch 18, 2024 | msn.comExagen reports Q4 resultsMarch 18, 2024 | investorplace.comXGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023March 18, 2024 | msn.comAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksMarch 18, 2024 | globenewswire.comExagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsMarch 18, 2024 | finance.yahoo.comXGN Apr 2024 2.500 putMarch 16, 2024 | insidertrades.comInsider Selling: Exagen Inc. (NASDAQ:XGN) CFO Sells 12,784 Shares of StockMarch 8, 2024 | finance.yahoo.comExagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumMarch 8, 2024 | globenewswire.comExagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumMarch 7, 2024 | globenewswire.comExagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024February 6, 2024 | finance.yahoo.comDespite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain StockJanuary 30, 2024 | finance.yahoo.comExagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 8, 2024 | msn.comExagen reaffirms FY23 revenue of at least $50MJanuary 7, 2024 | finance.yahoo.comExagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms GuidanceDecember 30, 2023 | benzinga.comExagen Stock (NASDAQ:XGN) Dividends: History, Yield and DatesDecember 20, 2023 | msn.comExagen submits plans for new solar farm in WiltshireNovember 17, 2023 | msn.comExagen files for a $150M mixed shelf offeringNovember 14, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Exagen (XGN) and Milestone Pharmaceuticals (MIST)November 13, 2023 | msn.comExagen GAAP EPS of -$0.31 beats by $0.15, revenue of $13.4M beats by $3.07MNovember 13, 2023 | finance.yahoo.comExagen Inc. Reports Strong Third Quarter 2023 ResultsNovember 12, 2023 | markets.businessinsider.comHere's what to expect from Exagen's earnings reportNovember 10, 2023 | benzinga.comEarnings Preview For ExagenNovember 9, 2023 | msn.comExagen licenses lupus nephritis biomarkers from Johns HopkinsNovember 9, 2023 | finance.yahoo.comExagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis BiomarkersNovember 2, 2023 | finance.yahoo.comExagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 1, 2023 | morningstar.comExagen Inc Ordinary Shares XGN Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto for AI (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.” Learn more about it by watching THIS NOW. XGN Media Mentions By Week XGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XGN News Sentiment▼0.810.42▲Average Medical News Sentiment XGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XGN Articles This Week▼181▲XGN Articles Average Week Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DMTK News PMD News CNTG News BGLC News ENZ News PSNL News FEMY News THTX News NMTC News VIRX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XGN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyThe #1 Crypto for AIWeiss Ratings**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.